Acute hepatitis in a patient treated with saquinavir and ritonavir: Absence of cross-toxicity with indinavir

被引:2
作者
Vandercam, B
Moreau, M
Horsmans, C
Gala, JL
机构
[1] Clin Univ St Luc, Dept Internal Med, B-1200 Brussels, Belgium
[2] Clin Univ St Luc, Dept Gastroenterol, B-1200 Brussels, Belgium
[3] Belgian Armed Forces, Queen Astrid Mil Hosp, B-1120 Brussels, Belgium
关键词
D O I
10.1007/BF02962257
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:313 / 313
页数:1
相关论文
共 4 条
[1]   Protease inhibitors in patients with HIV disease - Clinically important pharmacokinetic considerations [J].
Barry, M ;
Gibbons, S ;
Back, D ;
Mulcahy, F .
CLINICAL PHARMACOKINETICS, 1997, 32 (03) :194-209
[2]   Severe hepatitis in three AIDS patients treated with indinavir [J].
Brau, N ;
Leaf, HL ;
Wieczorek, RL ;
Margolis, DM .
LANCET, 1997, 349 (9056) :924-925
[3]   Severe hepatitis in patients with AIDS and haemophilia B treated with indinavir [J].
Matsuda, J ;
Gohchi, K .
LANCET, 1997, 350 (9074) :364-364
[4]   Pharmacokinetic interactions between antiepileptic drugs - Clinical considerations [J].
Riva, R ;
Albani, F ;
Contin, M ;
Baruzzi, A .
CLINICAL PHARMACOKINETICS, 1996, 31 (06) :470-493